About Karius
Karius is a company based in Redwood City (United States) founded in 2014 by Tim Blauwkamp. Karius has raised $315 million across 5 funding rounds from investors including Tencent, Lightspeed Venture Partners and Khosla Ventures. Karius offers products and services including Karius Spectrum. Karius operates in a competitive market with competitors including Prenetics, Inflammatix, Day Zero Diagnostics, MeMed and Visby Medical, among others.
- Headquarter Redwood City, United States
- Founders Tim Blauwkamp
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Karius, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$315 M (USD)
in 5 rounds
-
Latest Funding Round
$100 M (USD), Series C
May 02, 2024
-
Investors
Tencent
& 14 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Karius
Karius offers a comprehensive portfolio of products and services, including Karius Spectrum.
Non-invasive blood test detecting pathogens for infectious disease diagnosis.
People of Karius
Unlock access to complete
Unlock access to complete
Funding Insights of Karius
Karius has successfully raised a total of $315M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $100 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Karius
Karius has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Lightspeed Venture Partners and Khosla Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Venture capital fund backed incubator focused on the healthcare startups
|
Locked | Locked | Locked | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Locked | Locked | Locked |
Investor details for Karius
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Karius
Investment portfolio details for Karius
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Karius
Detailed financials for Karius
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Karius Comparisons
Peer comparison for Karius
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Karius
Karius operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Inflammatix, Day Zero Diagnostics, MeMed and Visby Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
Detailed competitors of Karius
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Karius
Complete news archive for Karius
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Karius
Karius was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Karius is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Alec Ford is the current CEO of Karius.
Karius is a funded company, having raised a total of $315M across 5 funding rounds to date.
Karius was founded in 2014 and is headquartered in Redwood City, United States. The company operates in the health technology sector, focusing on diagnostics for infectious diseases. A single blood sample is analyzed through the Karius Test, which employs genomics and artificial intelligence to identify microbial pathogens. This approach supports clinicians in making informed treatment decisions quickly, without invasive procedures.
Karius's top competitors include Visby Medical, Inflammatix and Prenetics.
Karius offers Karius Spectrum.
Karius has 15 investors. Key investors include Tencent, Lightspeed Venture Partners, Khosla Ventures, Oxford Finance, and SoftBank Vision Fund.